Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac
Condition(s):Leukemia, T-Cell; Lymphoma, T-Cell, CutaneousLast Updated:March 4, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Leukemia, T-Cell; Lymphoma, T-Cell, CutaneousLast Updated:March 4, 2008Completed
Condition(s):Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 InfectionLast Updated:March 6, 2024Recruiting
Condition(s):Adult T-cell Leukemia-Lymphoma; Peripheral T-cell LymphomaLast Updated:November 8, 2019Completed
Condition(s):Lymphoma; Adult T-Cell Leukemia/Lymphoma; Lymphatic DiseasesLast Updated:December 19, 2023Active, not recruiting
Condition(s):T Cell Leukemia, Adult; Leukemia, Adult T-Cell; T Cell Leukemia, HTLV I AssociatedLast Updated:January 10, 2023Terminated
Condition(s):Acute T-Cell Leukemia-LymphomaLast Updated:October 31, 2012Completed
Condition(s):T-cell Leukemia/Lymphoma; Refractory T Lymphoblastic Leukemia/Lymphoma; Relapse/RecurrenceLast Updated:August 2, 2022Recruiting
Condition(s):Leukemia, Adult T-CellLast Updated:November 19, 2019Terminated
Condition(s):T-Cell Lymphoma Relapsed; Adult T-Cell Leukemia (ATL); Peripheral T-Cell Lymphoma (PTCL); Cutaneous T Cell Lymphoma (CTCL); T-Cell Prolymphocytic LeukemiaLast Updated:April 29, 2022Completed
Condition(s):Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Adult T-Cell Leukemia/Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaLast Updated:January 31, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.